Darling Ingredients (DAR) Q2 2025: Fat Prices Jump $0.14/lb, Resetting Feed Margin Trajectory

July 24, 2025 | By EarningsIQ Research

Darling Ingredients’ Q2 2025 revealed a decisive inflection in feed margins as domestic fat prices surged, offsetting regulatory drag in renewables and positioning the core business for sequential improvement into 2026. Management’s tone highlighted policy clarity and operational discipline as key drivers for the second half, while capital allocation remains tightly focused on deleveraging ahead of anticipated margin tailwinds. Investors should track fat price flow-through, DGD utilization, and the NextIDA health and wellness JV as forward catalysts.

Summary

• Fat Price Acceleration: Domestic fat prices rose sharply, driving feed margin expansion and resetting segment expectations.
• Renewables Policy Overhang: Regulatory delays and RIN uncertainty weighed on DGD, but clarity is expected to unlock margin upside.
• Strategic Diversification: NextIDA JV in health and wellness signals a pivot to higher-margin, science-driven earnings streams.

Performance Analysis

Q2 marked a clear operational and margin inflection for Darling’s core feed segment, as rising domestic fat prices—up $0.10 to $0.14 per pound over Q2—drove notable gross margin improvement. Feed segment sales and EBITDA grew on steady volumes, with gross margins rising to 22.9% from 21.0% YoY. This was achieved despite protein price headwinds from tariff volatility and increased domestic oilseed crush, which pressured export pricing, particularly to Asia. Fat price outperformance more than offset these challenges, and management expects the favorable pricing environment to persist as policy shifts further restrict foreign feedstock imports.

The food segment also delivered higher sales and stable margins, with collagen and gelatin demand strengthening globally. However, EBITDA was slightly down YoY due to short-term capacity and market adjustments, though year-to-date EBITDA improved. The fuel segment remained under pressure, with Darling’s share of DGD EBITDA dropping sharply YoY, reflecting continued regulatory uncertainty and delayed RIN compliance. Despite this, gross margins improved at the company level (23.3% vs. 22.5% YoY), and capital discipline was evident in lower leverage and steady CapEx.

• Feed Margin Reset: Fat price gains flowed through to segment margin, overcoming protein softness and procurement lags.
• Renewables Drag: DGD EBITDA contribution fell as policy delays and SRE uncertainty persisted, but volume and margin recovery is expected with regulatory clarity.
• Balance Sheet Strengthening: Refinancing and reduced leverage (down to 3.34x) enhanced flexibility for future capital deployment.

Operational momentum in core ingredients is setting up for sequential improvement, with management guiding to full-year adjusted EBITDA of $1.05–$1.1 billion, and core business EBITDA of $900 million to $1 billion—excluding potential RIN upside from DGD.

Executive Commentary

Strategic Positioning

1. Feed Segment: Domestic Fat Advantage

Policy-driven restrictions on foreign feedstock imports have shifted the market in favor of domestic fat, a high-energy byproduct used in animal feed and renewable fuels. Management emphasized that this tailwind is both structural and sustainable, as U.S. fat pricing continues to benefit from reduced competition and increased demand from renewable diesel production. The company’s focus on operational reliability and maximizing domestic fat output is translating to higher realized margins and improved earnings visibility.

2. Renewables: Navigating Regulatory Uncertainty

The fuel segment, anchored by Diamond Green Diesel (DGD, renewable diesel JV), remains challenged by regulatory delays, particularly around small refinery exemptions (SREs) and RIN (Renewable Identification Number, a compliance credit) enforcement. DGD 1 remains offline, and DGD 3 is undergoing a planned turnaround. Management expects these assets to return to full utilization in 2026, once policy clarity and market signals (RIN and LCFS, Low Carbon Fuel Standard credits) improve. Current guidance is conservative, with upside potential if regulatory headwinds abate sooner than expected.

3. Food & Health: NextIDA JV and Collagen Upside

The announcement of the NextIDA joint venture marks a strategic push into health and wellness, leveraging Darling’s expertise in collagen and gelatin. Early scientific studies on NextIDA GC (a glucose-control peptide) are showing promising results, with repeat orders and large consumer packaged goods (CPG) companies evaluating the product. Management sees significant long-term EBITDA potential, with material contribution expected as early as 2026. This move diversifies earnings and positions Darling in a high-growth, high-margin vertical.

4. Capital Allocation: Deleveraging and Disciplined Growth

Darling’s refinancing efforts—upsizing its Euro bond and replacing term loans—have locked in borrowing costs and extended maturities, reducing leverage to 3.34x. CapEx is being tightly managed (targeting sub-$400 million for 2025), with a clear priority on debt reduction before considering dividends or buybacks. New growth investments are being paced to match balance sheet progress and policy clarity.

5. Global Diversification: Brazil and Export Strategy

Brazil’s rendering operations continue to perform well, benefiting from strong local biofuel demand and rising cattle numbers. While U.S. regulatory changes may shift global trade flows, Darling’s diversified geographic footprint and ability to redirect product to Europe or other markets provides resilience and optionality.

Key Considerations

This quarter’s results underscore an inflection in feed margins and reinforce Darling’s pivot to a more resilient, diversified business model. The balance between operational execution and regulatory navigation will define near-term results, while new growth vectors in health and wellness offer long-term optionality.

Key Considerations:

• Fat Price Flow-Through: Investors should monitor how quickly rising fat prices are realized in segment margins as procurement lags normalize.
• Renewables Policy Timing: The pace of SRE resolution and RIN market response will determine the magnitude and timing of DGD’s margin recovery.
• NextIDA Commercialization: Early traction and scientific validation in the health and wellness JV could meaningfully shift earnings mix by 2026.
• Capital Allocation Discipline: Ongoing deleveraging and CapEx restraint signal risk aversion, but may limit near-term growth acceleration.
• Global Supply Chain Flexibility: Ability to redirect product flows amid shifting tariffs and regional mandates remains a competitive advantage.

Risks

Regulatory uncertainty remains the primary risk, with delayed RIN compliance and SRE announcements limiting visibility for DGD and renewable fuel margins. Feedstock price volatility and procurement lags could pressure near-term margins if market dynamics reverse. Execution risk in scaling NextIDA and maintaining capital discipline amid policy shifts also warrants close monitoring.

Forward Outlook

For Q3 2025, Darling expects:

• Sequential improvement in feed margin as fat price gains flow through
• DGD volumes to be lower due to planned turnaround, with full utilization targeted for 2026

For full-year 2025, management guided:

• Combined adjusted EBITDA of $1.05–$1.1 billion
• Core business EBITDA of $900 million to $1 billion, with upside if RINs recover

Management highlighted:

• Continued strength in core ingredients and rising fat prices as key drivers
• Potential for upside in DGD margins if policy clarity arrives sooner than modeled

Takeaways

Darling’s Q2 results mark a pivotal shift in feed economics and set the stage for margin recovery as regulatory and policy headwinds abate.

• Feed Margin Inflection: Rising fat prices and operational discipline are driving sustained improvement in the core business, resetting expectations for margin performance.
• Renewables Await Policy Clarity: DGD’s contribution remains muted until RIN and SRE issues are resolved, but structural demand for renewable diesel and SAF remains intact.
• Health and Wellness Optionality: NextIDA JV and pipeline of science-driven products could diversify and accelerate earnings growth from 2026 onward.

Conclusion

Darling Ingredients enters the back half of 2025 with clear momentum in its core feed business, disciplined capital management, and a strategic pivot toward higher-margin, diversified growth. Regulatory timing remains the wild card, but operational fundamentals and new growth platforms position the company for a stronger 2026.

Industry Read-Through

Darling’s results reinforce a broader industry pivot toward domestic feedstock advantage as U.S. policy restricts foreign imports and supports local fat pricing. Renewable fuel producers face continued margin volatility until regulatory clarity on RINs and SREs emerges, a dynamic likely to impact peers across the biofuels and ag supply chain. Emerging health and wellness platforms, such as collagen and peptide-based functional ingredients, represent a secular growth vector that other ag processors and ingredient suppliers may increasingly pursue to diversify away from commodity cyclicality.

DAR Materials Specialty Chemicals Renewable Fuels Feed Ingredients Health and Wellness Deleveraging Capital Allocation